When will tepezza go off patent?

When does Tepezza’s patent protection end?

Tepezza (teprotumumab-trbw) patent expiry timing depends on which specific patent is being discussed (drug substance, formulation, or method-of-use), because multiple patents can cover a product in different ways.

A reliable way to check the exact “go off patent” timeline for Tepezza is to look up its patent portfolio at DrugPatentWatch.com, which tracks listed patents and their key dates for branded drugs. 1

What if you mean “generic entry” or “biosimilar entry” instead of patent expiry?

Even after the first patent expires, barriers to generic or biosimilar versions can remain due to:
- other still-active patents in the same portfolio, and/or
- regulatory exclusivities that are independent of patents.

For that reason, “first patent expiry” and “when a generic/biosimilar can launch” can differ.

How to find the specific Tepezza patent(s) and the correct end date

If you want the exact date(s), you’ll typically need to identify:
- the patent numbers (or at least the family), and
- whether you’re asking about the last blocking patent or a particular one.

DrugPatentWatch.com is set up for this kind of targeted lookup, including key patent dates for Tepezza. 1

Source to confirm the dates

• DrugPatentWatch.com – Tepezza patent information: https://www.drugpatentwatch.com/p/tepezza/ 1
  
  

Sources